Tuesday, June 27, 2023
Techsomed Ltd., a developer specializing in medical software, has announced the commencement of a field evaluation for its BioTraceIO360 software in collaboration with GE HealthCare's LOGIQ™ E10 Series ultrasound imaging technology. The purpose of this evaluation is to assess the effectiveness of the software in improving visualization and control during liver ablation procedures.
Liver ablation therapy is a minimally invasive treatment method for liver tumors. However, the lack of comprehensive visualization during the procedure often results in a significant gap between the planned treatment and the actual outcomes achieved. This discrepancy can lead to potential risks, such as damage to healthy tissue or incomplete destruction of tumor cells, contributing to higher rates of local tumor recurrence.
Techsomed's BioTrace platform, currently undergoing advanced clinical evaluation, represents a noteworthy advancement in Image-Guided Ablation Therapy. By incorporating standard imaging techniques like ultrasound (US), computed tomography (CT), or magnetic resonance imaging (MRI), the BioTrace software aims to provide real-time visualization of the complete ablation zone. Additionally, it offers intelligent treatment planning and assessment tools, allowing physicians to deliver personalized and optimized care to their patients.
Source: prnewswire.com
